Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD of Levonorgestrel Butanoate Injections for Contraception
NCT04143659Phase 1Active, not recruiting
- Sponsor
- Premier Research
- Start
- Mar 2020
- Primary completion
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of levonorgestrel butanoate in contraception (5 arms), sponsored by Premier Research. Primary endpoint: Measurement of levonorgestrel serum concentrations. Started Mar 2020; status: active, not recruiting.
02
Drugs
levonorgestrel butanoate
03
Conditions
contraception
Beyond the preview
Go deeper on NCT04143659.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04143659.